Eyebright Medical Technology (Beijing) Management
Management criteria checks 4/4
Eyebright Medical Technology (Beijing)'s CEO is Jiangbing Xie, appointed in Jun 2019, has a tenure of 5.58 years. directly owns 12.92% of the company’s shares, worth CN¥2.27B. The average tenure of the management team and the board of directors is 4.1 years and 5.2 years respectively.
Key information
Jiangbing Xie
Chief executive officer
CN¥1.3m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.6yrs |
| CEO ownership | 12.9% |
| Management average tenure | 4.1yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
We Think That There Are Some Issues For Eyebright Medical Technology (Beijing) (SHSE:688050) Beyond Its Promising Earnings
Nov 06
Returns At Eyebright Medical Technology (Beijing) (SHSE:688050) Are On The Way Up
Oct 18Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable
Oct 01Eyebright Medical Technology (Beijing) Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 23Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)
Jul 15Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings
Jun 10Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?
May 13Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues
Apr 24Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think
Apr 21Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Mar 25A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)
Mar 18Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)
Mar 01CEO
Jiangbing Xie (52 yo)
5.6yrs
Tenure
CN¥1,321,800
Compensation
Mr. Jiangbing Xie serves as Chairman of the Board and General Manager at Eyebright Medical Technology (Beijing) Co., Ltd. since June 2019 and is its Chief Scientist.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 5.6yrs | CN¥1.32m | 12.92% CN¥ 2.3b | |
| Deputy GM & National Marketing Director | 5.6yrs | CN¥1.61m | 0.0036% CN¥ 629.8k | |
| Deputy GM | 2.6yrs | CN¥894.60k | 0.0069% CN¥ 1.2m | |
| Assistant to the GM & Board Secretary | 2.6yrs | CN¥567.30k | 0.0064% CN¥ 1.1m |
4.1yrs
Average Tenure
44yo
Average Age
Experienced Management: 688050's management team is considered experienced (4.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 5.6yrs | CN¥1.32m | 12.92% CN¥ 2.3b | |
| Deputy GM | 4.8yrs | CN¥894.60k | 0.0069% CN¥ 1.2m | |
| Director | 5.6yrs | no data | no data | |
| Independent Director | 5.6yrs | CN¥160.00k | no data | |
| Independent Director | 3yrs | CN¥160.00k | no data | |
| Employee Supervisor | 5.6yrs | no data | no data | |
| Director | 2.6yrs | no data | no data | |
| Supervisor | 2.6yrs | no data | no data |
5.2yrs
Average Tenure
50yo
Average Age
Experienced Board: 688050's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/04 06:58 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Eyebright Medical Technology (Beijing) Co., Ltd. is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| Yichi Zhang | China International Capital Corporation Limited |
| Feifei Xu | China Merchants Securities Co. Ltd. |